Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-22-218732
Filing Date
2022-08-11
Accepted
2022-08-11 17:24:13
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d361810d424b5.htm 424B5 7146
2 GRAPHIC g361810g0811082641250.jpg GRAPHIC 4103
  Complete submission text file 0001193125-22-218732.txt   13958
Mailing Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121
Business Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

EIN.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-254063 | Film No.: 221157010
SIC: 2834 Pharmaceutical Preparations